
Metastatic Bladder Cancer — Rapid Case Review Issue 3
Oncology Today with Dr Neil Love
00:00
Case: FGFR3 and HER2 biomarkers after adjuvant IO
Nazli Dizman presents a post‑cystectomy patient with FGFR3 mutation and HER2 IHC3+ progression after adjuvant pembrolizumab.
Play episode from 12:37
Transcript


